West Family Investments’s AbbVie ABBV Stock Holding History

West Family Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$999K	Sell	3,970 -900	-18%	-$194K	0.29%	57
2026 Q1	$1.06M	Sell	4,870 -4,215	-46%	-$935K	0.37%	43
2025 Q4	$2.08M	Sell	9,085 -965	-10%	-$220K	0.49%	28
2025 Q3	$2.33M	Buy	10,050 +90	+0.9%	+$18.3K	0.52%	30
2025 Q2	$1.85M	Buy	9,960 +2,862	+40%	+$532K	0.48%	32
2025 Q1	$1.49M	Buy	7,098 +3	+0%	+$583	0.56%	34
2024 Q4	$1.26M	Sell	7,095 -130	-2%	-$23.9K	0.44%	45
2024 Q3	$1.43M	Buy	7,225 +706	+11%	+$132K	0.49%	40
2024 Q2	$1.12M	Sell	6,519 -26	-0.4%	-$4.31K	0.34%	63
2024 Q1	$1.19M	Buy	6,545 +319	+5%	+$55K	0.37%	55
2023 Q4	$965K	Sell	6,226 -422	-6%	-$61.5K	0.33%	61
2023 Q3	$991K	Sell	6,648 -167	-2%	-$24.5K	0.35%	61
2023 Q2	$918K	Buy	6,815 +638	+10%	+$93.6K	0.36%	62
2023 Q1	$984K	Sell	6,177 -294	-5%	-$44.9K	0.39%	62
2022 Q4	$1.05M	Buy	6,471 +1,064	+20%	+$163K	0.36%	58
2022 Q3	$726K	Buy	5,407 +214	+4%	+$30.7K	0.3%	74
2022 Q2	$795K	Buy	5,193 +78	+2%	+$11.9K	0.31%	61
2022 Q1	$829K	Buy	5,115 +12	+0.2%	+$1.74K	0.24%	70
2021 Q4	$691K	Sell	5,103 -609	-11%	-$71.9K	0.19%	96
2021 Q3	$616K	Buy	5,712 +387	+7%	+$44.2K	0.16%	117
2021 Q2	$600K	Buy	+5,325	New	+$600K	0.16%	108
2018 Q1	–	Sell	-22,000	Closed	-$2.13M	–	86
2017 Q4	$2.13M	Hold	22,000	–	–	0.55%	42
2017 Q3	$1.96M	Hold	22,000	–	–	0.24%	42
2017 Q2	$1.36M	Hold	22,000	–	–	0.3%	62
2017 Q1	$1.43M	Hold	22,000	–	–	0.28%	57
2016 Q4	$1.38M	Hold	22,000	–	–	0.24%	60
2016 Q3	$1.39M	Hold	22,000	–	–	0.26%	63
2016 Q2	$1.36M	Hold	22,000	–	–	0.25%	64
2016 Q1	$1.26M	Hold	22,000	–	–	0.21%	66
2015 Q4	$1.3M	Hold	22,000	–	–	0.33%	59
2015 Q3	$1.2M	Hold	22,000	–	–	0.25%	61
2015 Q2	$1.48M	Hold	22,000	–	–	0.31%	55
2015 Q1	$1.29M	Hold	22,000	–	–	0.26%	55
2014 Q4	$1.44M	Hold	22,000	–	–	0.28%	52
2014 Q3	$1.27M	Hold	22,000	–	–	0.27%	51
2014 Q2	$1.24M	Hold	22,000	–	–	0.26%	53
2014 Q1	$1.13M	Hold	22,000	–	–	0.25%	52
2013 Q4	$1.16M	Hold	22,000	–	–	0.27%	54
2013 Q3	$984K	Hold	22,000	–	–	0.25%	57
2013 Q2	$910K	Buy	+22,000	New	+$962K	0.24%	58

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

West Family Investments's ABBV Position: Q2 2026 in Review

West Family Investments reduced its AbbVie (ABBV) stake by 18% in Q2 2026, selling an estimated $194K and leaving 3,970 shares worth $999K. The position accounts for 0.29% of the portfolio, ranked #57.

West Family Investments first reported a position in ABBV in Q2 2013 and has held it in 40 quarters since. The position peaked at $2.33M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

West Family Investments held 3,970 shares of AbbVie worth $999K as of Q2 2026.
West Family Investments sold 900 AbbVie shares in Q2 2026, an estimated $194K.
AbbVie made up 0.29% of West Family Investments's portfolio in Q2 2026, its #57 holding.
West Family Investments first reported a position in AbbVie in Q2 2013 and has held it in 40 quarters since.
West Family Investments's AbbVie position peaked at $2.33M in Q3 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.